Meet CBD, THC’s Non-Psychotropic Sibling

The cannabis extract is creating lots of buzz, but is the science there to back it up?

By Stefan Milne July 17, 2018 Published in the August 2018 issue of Seattle Met

Shutterstock by Andris Tkacenko

Hempfest, our city’s annual paean to pot, returns this August for its 27th year. But lately most of the buzz around cannabis has centered on CBD (cannabidiol), THC’s non-psychotropic sibling. In the last couple years, it’s become increasingly available at healthfood stores, in head shops, and, for a time, in cafes. Proponents claim it has minimal side effects and could relieve everything from anxiety to schizophrenia. Local government is less convinced.


Show Comments